Fungal infections in heart transplant patients (2008–2022)
Part of Infections clinical trials.
This study looks back at heart transplant patients who had a serious fungal infection from thread-like fungi (like mold) between 2008 and 2022. It aims to learn more about these infections to improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have had a heart transplant.
- Between January 2008 and December 2022, you had a serious fungal infection caused by a thread-like fungus (like aspergillus or mucor).
- The infection was confirmed by a doctor using specific criteria.
- You have not told the doctors you don't want your data used for this research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for fungal infections in hospitalized patients. It aims to understand how common serious fungal infections are, especially in people with weakened immune systems or certain medical conditions.
This trial looks at lab test results from samples taken to check for a serious (invasive) fungal infection caused by fusarium. It may help improve how doctors identify the infection and its drug resistance, which can guide better treatment.
This study looks at whether repeated PCR tests for a fungus called Aspergillus fumigatus (in blood or lung fluid) can help doctors track how well treatment is working for a serious lung infection called invasive aspergillosis. It is for people who already had a positive PCR test at diagnosis.
This study looks back at patient records to learn more about fungal infections in vascular grafts (artificial blood vessel replacements). It aims to better understand how to diagnose and treat these rare but serious infections.
This study looks at a rare gut infection (microsporidiosis) in people who have had a heart transplant. If you had this infection before 2025 and the diagnosis was made in France, your medical records may be reviewed to learn more about the infection.
This study tracks how your immune system responds to serious mold infections, like aspergillosis or mucormycosis. It may help doctors understand why some infections are hard to treat and could lead to better care.
Hear when a new Invasive Fungal Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.